Clinical Trial Update: Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating amlodipine for prevention and treatment of iron overload in patients with thalassemia major; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload
• Thalassemia

Drugs mentioned

• Amlodipine (amlodipine)

Snippet

Sponsor: University of Campinas, Brazil | Conditions: Thalassemia, Iron Overload | Phase 3 | Status: COMPLETED